[1]
|
American Psychiatric Association (2000). Diagnostic and statistics manual of mental disorders (4th ed.). Arlington, VA: Text Revision (DSM-IV-TR).
|
[2]
|
Andreas, S., Anker, S. D., Scanlon, P. D., & Somers, V. K. (2005). Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest, 128, 3618-3624.
doi:10.1378/chest.128.5.3618
|
[3]
|
Beck, A. T., & Steer, R. A. (1996). Beck anxiety inventory: Manual. San Antonio, TX: The Psychological Corporation.
|
[4]
|
Borak, J., Sliwinski, P., Piasecki, Z., & Zielinski, J. (1991). Psychological status of COPD patients on long term oxygen therapy. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology, 4, 59-62.
|
[5]
|
Bender, R. E., & Allow, L. B. (2011). Life stress and kindling in bipolar disorder: Review of the evidence and integration with emerging biopsychosocial theories. Clinical Psychology Review, 31, 383-398.doi:10.1016/j.cpr.2011.01.004
|
[6]
|
Brenes, G. A. (2003). Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosomatic Medicine, 65, 963-970. doi:10.1097/01.PSY.0000097339.75789.81
|
[7]
|
Cafarella, P. A., Effing, T. W., Usmani, Z., & Frith, P. A. (2012). Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: A literature review. Respirology, 17, 627-638. doi:10.1111/j.1440-1843.2012.02148.x
|
[8]
|
Coventry, P.A. (2009). Does pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease? Current Opinion in Pulmonary Medicine, 15, 143-149. doi:10.1097/MCP.0b013e3283218318
|
[9]
|
Di Marco, F., Verga, M., Reggente, M., Maria Casanova, F., Santus, P., Blasi F., Allegra, L., & Centanni, S. (2006). Anxiety and depression in COPD patients: The roles of gender and disease severity. Respiratory Medicine, 100, 1767-1774. doi:10.1016/j.rmed.2006.01.026
|
[10]
|
Eiser, N., West, C., Evans, S., Jeffers, A., & Quirk F. (1997). Effects of psychotherapy in moderately severe COPD: A pilot study. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology, 10, 1581-1584. doi:10.1183/09031936.97.10071581
|
[11]
|
Ferguson, C. J., Stanley, M., Souchek, J., & Kunik, M. E. (2006). The utility of somatic symptoms as indicators of depression and anxiety in military veterans with chronic obstructive pulmonary disease. Depression and Anxiety, 23, 42-49. doi:10.1002/da.20136
|
[12]
|
Fricchione, G. (2004). Generalized anxiety disorder. New England Journal of Medicine, 351, 675-682. doi:10.1056/NEJMcp022342
|
[13]
|
Heindl, S., Lehnert, M., Criee, C.-P., Hasenfuss G., & Andreas, S. (2001). Marked sympathetic activation in patients with chronic respiratory failure. American Journal of Respiratory and Critical Care Medicine, 164, 597-601.
|
[14]
|
Hynninen, K. M., Breitve, M. H., Wiborg, A. B., Pallesen, S., & Nordhus, I. H. (2005). Psychological characteristics of patients with chronic obstructive pulmonary disease: A review. Journal of psychosomatic research, 59, 429-443.
doi:10.1016/j.jpsychores.2005.04.007
|
[15]
|
Hill, K., Geist, R., Goldstein, R. S., & Lacasse, Y. (2008). Anxiety and depression in end-stage COPD. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology, 31, 667-677. doi:10.1183/09031936.00125707
|
[16]
|
Jetty, R. V., Charney, D. S., & Goddard, A. W. (2001). Generalized anxiety disorder. Psychiatric Clinics of North America, 24, 75-97.doi:10.1016/S0193-953X(05)70207-0
|
[17]
|
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 593-602. doi:10.1001/archpsyc.62.6.593
|
[18]
|
Kunik, M. E., Roundy, K., Veazey, C., Souchek, J., Richardson, P., Wray, N. P., & Stanley, M. A. (2005). Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest, 127, 1205-1211. doi:10.1378/chest.127.4.1205
|
[19]
|
Laurin, C., Moullec, G., Bacon, S. L., & Lavoie, K. L. (2012). Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. American Journal of Respiratory and Critical Care Medicine, 185, 918-923. doi:10.1164/rccm.201105-0939PP
|
[20]
|
Light, R. W., Merrill, E. J., Despars, J. A., Gordon, G. H., & Mutalipassi, L. R. (1985). Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. Chest, 87, 35-38. doi:10.1378/chest.87.1.35
|
[21]
|
Parshall, M. B., Schwartzstein, R. M., Adams, L., Banzett, R. B., Manning, H. L., Boubeau, J., Calverley, P. M., Gift, A. G., Harver, A., Lareau, S. C., Mahler, D. A., Meek, P. M., & O’Donnell, D. E. (2012). An official American Thoracic Society statement: Update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine, 185, 435-452.doi:10.1164/rccm.201111-2042ST
|
[22]
|
Post, R. M., Fleming, J., & Kapczinsk, F. (2012). Neurobiological correlates of illness progression in the recurrent affective disorders. Journal of Psychiatric Research, 46, 561-573.doi:10.1016/j.jpsychires.2012.02.004
|
[23]
|
Salpeter, S. R., Ormiston, T. M., & Salpeter, E. E. (2004). Cardiovascular effects of β-agonists in patients with asthma and COPD: A meta- analysis. Chest, 125, 2309-2321. doi:10.1378/chest.125.6.2309
|
[24]
|
Von Leupoldt, A., Sommer, T., Kegat, S., Baumann,H. J., Klose, H., Dahme, B., & Buchel, C. (2008). The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdale. American Journal of Respiratory and Critical Care Medicine, 177, 1026-1032.doi:10.1164/rccm.200712-1821OC
|
[25]
|
Wennlund, B. T., & Carlstrom, K. (2000). Impact of hypoxaemia on neuroendocrine function and catecholamine secretion in chronic obstructive pulmonary disease (COPD). Effects of lung-term oxygen treatment. Respiratory Medicine, 94, 1221-1228.
doi:10.1053/rmed.2000.0953
|
[26]
|
Xu, W., Collet, J. P., Shapiro, S., Lin, Y., Yang, T., Platt, R. W., Wang, C., & Bourbeau, J. (2008). Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. American Journal of Respiratory and Critical Care Medicine, 178, 913-920. doi:10.1164/rccm.200804-619OC
|
[27]
|
Yohannes, A. M., Baldwin, R. C., & Connolly, M. J. (2000). Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: Prevalence, and validation of the BASDEC screening questionnaire. International Journal of Geriatric Psychiatry, 15, 1090-1096. doi:10.1002/1099-1166(200012)15:12<1090::AID-GPS249>3.0.CO;2-L
|
[28]
|
Zandbergen, J., Bright, M., Pols, H., Fernandez, I., de Loof, C., & Griez, E. J. (1991). Higher lifetime prevalence of respiratory diseases in panic disorder? The American Journal of Psychiatry, 148, 1583- 1585.
|
[29]
|
Ziemann, E., Allen, J. E., Dahdaleh, N. S., Drebo, I. I., Coryell, M. W., Wunsch, A. M., Lynch, C. M., Faraci, F. M., Howard, M. A., Welsh, M. J., & Wemmie, J. A. (2009). The amygdale is a chemosensor that detects carbon dioxide and acidosis to elicit fear behavior. Cell, 139, 1012-1021. doi:10.1016/j.cell.2009.10.029
|